P/E ratio for Sanofi India Limited (SANOFI.NS)
P/E ratio as of April 2024 (TTM): 32.3
According to Sanofi India Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 32.3013. At the end of 2022 the company had a P/E ratio of 21.7.
P/E ratio history for Sanofi India Limited from 2012 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 21.7 | 12.93% |
| 2021 | 19.2 | -52.1% |
| 2020 | 40.2 | 3.08% |
| 2019 | 39.0 | 1.19% |
| 2018 | 38.5 | 16.13% |
| 2017 | 33.2 | 1.96% |
| 2016 | 32.5 | 3.59% |
| 2015 | 31.4 | -0.04% |
| 2014 | 31.4 | 31.45% |
| 2013 | 23.9 | -20.49% |
| 2012 | 30.0 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.